These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27744094)

  • 1. Identification of potential inhibitor and enzyme-inhibitor complex on trypanothione reductase to control Chagas disease.
    Hossain MU; Oany AR; Ahmad SAI; Hasan MA; Khan MA; Siddikey MAA
    Comput Biol Chem; 2016 Dec; 65():29-36. PubMed ID: 27744094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fast virtual screening approach to identify structurally diverse inhibitors of trypanothione reductase.
    Maccari G; Jaeger T; Moraca F; Biava M; Flohé L; Botta M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5255-8. PubMed ID: 21807515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Docking and Binding Mode Analysis of Plant Alkaloids as in vitro and in silico Inhibitors of Trypanothione Reductase from Trypanosoma cruzi.
    Argüelles AJ; Cordell GA; Maruenda H
    Nat Prod Commun; 2016 Jan; 11(1):57-62. PubMed ID: 26996020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
    Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasite-specific trypanothione reductase as a drug target molecule.
    Krauth-Siegel RL; Inhoff O
    Parasitol Res; 2003 Jun; 90 Suppl 2():S77-85. PubMed ID: 12709793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel aryl β-aminocarbonyl derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures.
    de Paula da Silva CH; Bernardes LS; da Silva VB; Zani CL; Carvalho I
    J Biomol Struct Dyn; 2012; 29(6):702-16. PubMed ID: 22546000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel virtual screening cascade protocol to identify potential trypanothione reductase inhibitors.
    Perez-Pineiro R; Burgos A; Jones DC; Andrew LC; Rodriguez H; Suarez M; Fairlamb AH; Wishart DS
    J Med Chem; 2009 Mar; 52(6):1670-80. PubMed ID: 19296695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
    Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
    J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
    Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
    J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of trypanothione reductase inhibitory activity by 1,3,4-thiadiazolium-2-aminide derivatives and molecular docking studies.
    Rodrigues RF; Castro-Pinto D; Echevarria A; dos Reis CM; Del Cistia CN; Sant'Anna CM; Teixeira F; Castro H; Canto-Cavalheiro M; Leon LL; Tomás A
    Bioorg Med Chem; 2012 Mar; 20(5):1760-6. PubMed ID: 22304847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
    Venkatesan SK; Shukla AK; Dubey VK
    J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations of peptide inhibitors complexed with Trypanosoma cruzi trypanothione reductase.
    Silva Da Rocha Pita S; Batista PR; Albuquerque MG; Pascutti PG
    Chem Biol Drug Des; 2012 Oct; 80(4):561-71. PubMed ID: 22702225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Exploration of the Trypanothione Reductase (TryR) of
    Barrera-Téllez FJ; Prieto-Martínez FD; Hernández-Campos A; Martínez-Mayorga K; Castillo-Bocanegra R
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
    Ruiz-Santaquiteria M; Sánchez-Murcia PA; Toro MA; de Lucio H; Gutiérrez KJ; de Castro S; Carneiro FAC; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    Eur J Med Chem; 2017 Jul; 135():49-59. PubMed ID: 28431354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
    Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent inhibitors of trypanothione reductase: analogues of the spermidine alkaloid lunarine and related natural products.
    Hamilton CJ; Saravanamuthu A; Poupat C; Fairlamb AH; Eggleston IM
    Bioorg Med Chem; 2006 Apr; 14(7):2266-78. PubMed ID: 16303308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the Trypanosoma cruzi trypanothione reductase.mepacrine complex.
    Jacoby EM; Schlichting I; Lantwin CB; Kabsch W; Krauth-Siegel RL
    Proteins; 1996 Jan; 24(1):73-80. PubMed ID: 8628734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.